Month: February 2021

AttachmentCGCBV_26.2_trades

LiiteCGCBV_26.2_trades

csBIC completes the divestiture of PIMACOClichy, France– 26 February 2021 –BIC announced today that it has completed the divestiture of its Brazilian adhesive label business, PIMACO, to Grupo CCRR for 40 million Brazilian Real (approximately 6.0 million euros1).The transaction was approved by the Brazilian antitrust authorities.This divestiture is consistent with BIC’s portfolio rotation strategy and its focus on fast-growing consumer businesses such as Creative Expression and Digital Writing.# #ABOUT BICA world leader in stationery, lighters and shavers, BIC brings simplicity and joy to everyday life. For more than 75 years, the Company has honored the tradition of providing high-quality, affordable, essential products to consumers everywhere. Through this unwavering dedication, BIC has become one of the most recognized brands and is...

BIC finalise la cession de PIMACOClichy, France– 26 février 2021 – BIC annonce la finalisation de la cession de PIMACO, son activité d’étiquettes adhésives au Brésil, à Grupo CCRR pour un montant de 40 millions de Real brésiliens (environ 6,0 millions d’euros1).La transaction a été approuvée par les autorités de la concurrence brésiliennes.Cette cession est cohérente avec la stratégie de rotation du portefeuille du Groupe, et la priorité accordée aux activités grand public à croissance rapide, telles que la créativité (“Creative Expression”) et l’écriture digitale.# #À PROPOS DE BICUn des leaders mondiaux des articles de papeterie, des briquets et des rasoirs, BIC enchante et simplifie le quotidien des consommateurs. Depuis plus de 75 ans, l’entreprise fabrique des produits essentiels de grande qualité et...

MIAMI, Feb. 26, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced plans to launch open testing of its KetaDASH ketamine IV therapy in the second quarter using advanced vein technology. KetaDASH is a personalized mental care platform designed to instantly connect patients with highly skilled nurses to provide ketamine therapy at home under expert supervision. The platform has been strategically designed as a smart and intuitive dashboard from where patients and their associated nurses can get detailed insight on treatments. KetaDASH will soon be available on the App Store and Google Play Store.Ehave has also secured an umbrella policy to cover liability and malpractice insurance on each home delivery service. Clinicians...

Tulsa, OK, Feb. 26, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — AppSwarm, Corp. (OTC: SWRM), a software development company and aggregator of mobile applications, to provide investor updates on their video conferencing and broadband projects.The company announces plans to provide periodic project updates on our video conferencing and broadband initiatives through our key advisory firm Deep Sky Wireless.Since the fourth quarter of 2020, Deep Sky Wireless has been instrumental in guiding us in the development of our technology plan and building value for our shareholders.To receive investor updates on our projects, please register at https://www.deepskywireless.com/investors/Establish Customer Support OperationsThe Company will explore the deployment of CRM applications to manage interactions with customers and potential customers....

VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) — International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) reports the following, in accordance with the Swedish Financial Instruments Trading Act:Following the exercise of stock options by Lukas H. Lundin during February 2021, the number of issued and outstanding common shares of the Corporation has increased by 25,000 to 155,367,757 common shares with voting rights as at February 26, 2021.International Petroleum Corp. (IPC) is an international oil and gas exploration and production company with a high quality portfolio of assets located in Canada, Malaysia and France, providing a solid foundation for organic and inorganic growth. IPC is a member of the Lundin Group of Companies. IPC is incorporated in Canada and IPC’s shares are listed...

CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced the exercise of 712,500 warrants from its June 2020 financing for net proceeds to the company of $1,425,000.About Adial Pharmaceuticals, Inc.Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated in the Company’s landmark ONWARD™ pivotal Phase 3 clinical trial for the potential treatment of AUD in subjects...

Reginn hf. og Landsbankinn hf. hafa endurnýjað samning um viðskiptavakt á hlutabréfum Regins hf. sem skráð eru í kauphöll Nasdaq Iceland.Tilgangur viðskiptavaktarinnar er að efla viðskipti með hlutabréf Regins í því skyni að markaðsverð skapist á hlutabréfum og verðmyndun verði með skilvirkum og gagnsæjum hætti.Landsbankinn hf. skuldbindur sig sem viðskiptavaki til að setja daglega fram kaup- og sölutilboð á Nasdaq Iceland í hlutabréf Regins hf. að lágmarki 15.000.000 kr. að markaðsvirði. Tilboð skulu endurnýjuð eins fljótt og unnt er, þó ávallt innan 15 mínútna eftir að þeim er tekið að fullu. Hámarksmagn sem Landsbankinn er skuldbundinn til að kaupa eða selja á hverjum degi er 30.000.000 kr. að nettó markaðsvirði sem reiknast sem mismunur á þeim kaup- og sölutilboðum viðskiptavakans sem gengið er að. Sé hámarksmagni dagsins náð, fellur...

MONTRÉAL, Feb. 26, 2021 (GLOBE NEWSWIRE) — Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or (the “Company”) wishes to announce that it has been in discussions with YA II PN, Ltd. and Riverfort Global Opportunities PLC (the “Lenders”) over claims that Elixxer is in default under the terms of its previously announced convertible loan agreement with the Lenders (see press release dated March 17, 2020). Negotiations towards arriving at a resolution are ongoing; however, if such negotiations prove to be unsuccessful, it may result in the Lenders instituting default proceedings against the Company in order to recover amounts owing pursuant to the loan in the amount of US$1,078,698, including accrued interest thereon. Although Elixxer has so far made several attempts to settle matters with the Lenders, including negotiations...